PRTA
Prothena Corporation plc

2,004
Mkt Cap
$495.24M
Volume
601,967.00
52W High
$16.67
52W Low
$4.32
PE Ratio
-1.77
PRTA Fundamentals
Price
$9.26
Prev Close
$9.20
Open
$9.16
50D MA
$9.97
Beta
1.03
Avg. Volume
769,467.45
EPS (Annual)
-$2.27
P/B
1.68
Rev/Employee
$829,184.05
Loading...
Loading...
News
all
press releases
Prothena Corporation plc (NASDAQ:PRTA) Receives Consensus Rating of "Hold" from Brokerages
Shares of Prothena Corporation plc (NASDAQ:PRTA - Get Free Report) have received an average recommendation of "Hold" from the twelve analysts that are presently covering the firm, Marketbeat Ratings...
MarketBeat·5d ago
News Placeholder
More News
News Placeholder
Fortrea Holdings Inc. (FTRE) Moves 5.5% Higher: Will This Strength Last?
Fortrea Holdings Inc. (FTRE) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock suggests that there could be more strength down the road.
Zacks·8d ago
News Placeholder
Squarepoint Ops LLC Takes $1.27 Million Position in Prothena Corporation plc $PRTA
Squarepoint Ops LLC purchased a new stake in shares of Prothena Corporation plc (NASDAQ:PRTA - Free Report) during the 2nd quarter, according to the company in its most recent filing with the...
MarketBeat·26d ago
News Placeholder
Prothena Corporation plc (NASDAQ:PRTA) Given Average Recommendation of "Hold" by Analysts
Shares of Prothena Corporation plc (NASDAQ:PRTA - Get Free Report) have earned an average rating of "Hold" from the twelve research firms that are presently covering the stock, Marketbeat Ratings...
MarketBeat·30d ago
News Placeholder
Birchview Capital LP Has $2.74 Million Stock Holdings in Prothena Corporation plc $PRTA
Birchview Capital LP boosted its position in shares of Prothena Corporation plc (NASDAQ:PRTA - Free Report) by 35.5% in the second quarter, according to its most recent Form 13F filing with the...
MarketBeat·1mo ago
News Placeholder
Prothena Announces Board of Directors Update
Prothena Corporation plc (NASDAQ:PRTA), a late-stage clinical biotechnology company with a robust pipeline of investigational therapeutics built on protein dysregulation expertise, today announced...
Business Wire·1mo ago
News Placeholder
Prothena Corporation plc $PRTA Shares Bought by Federated Hermes Inc.
Federated Hermes Inc. grew its holdings in Prothena Corporation plc (NASDAQ:PRTA - Free Report) by 116.2% during the 2nd quarter, according to its most recent Form 13F filing with the Securities and...
MarketBeat·1mo ago
News Placeholder
Prothena (NASDAQ:PRTA) Stock Price Up 7.4% - Here's Why
Prothena (NASDAQ:PRTA) Trading Up 7.4% - What's Next...
MarketBeat·1mo ago
News Placeholder
Citizens Jmp Forecasts Strong Price Appreciation for Prothena (NASDAQ:PRTA) Stock
Citizens Jmp upped their price target on Prothena from $11.00 to $19.00 and gave the company a "market outperform" rating in a report on Monday...
MarketBeat·1mo ago
News Placeholder
Prothena Corporation plc (NASDAQ:PRTA) Given Average Recommendation of "Hold" by Brokerages
Prothena Corporation plc (NASDAQ:PRTA - Get Free Report) has received a consensus rating of "Hold" from the ten analysts that are currently covering the firm, Marketbeat Ratings reports. Two...
MarketBeat·2mo ago
<
1
2
...
>

Latest PRTA News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.